Jude Onyia

Jude Onyia

atNeurocrine Biosciences· In proxies 2021–2025

Pay in FY2023+193% from the year before · Neurocrine Biosciences stock +10.3% the same year

Jude Onyia was paid $7.2M in FY2023 (Dec), up 193%. Neurocrine Biosciences stock rose 10.3% that year.

Pay$100 in the stock at the end of FY20 → $137
Pay is from the Summary Compensation Table of each Neurocrine Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Neurocrine BiosciencesPublic company · 5 yr
    • 2021 – Present · 5 yrStock in role +49%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?